Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Earnings Watch For Jan 29 (DHI, LLY, F, PFE, BSX, BRCM)

RELATED NEWS
Trade PFE now with 

Pfizer Inc. (PFE: Quote) is due to post its fourth quarter results. The pharmaceutical giant is expected to post earnings of $0.44 per share, lower than the year-ago quarter's $0.50 per share. Also, quarterly revenues are anticipated to decline to $14.37 billion from $16.75 billion in the prior-year quarter. PFE closed Monday at $26.84. (52-wk H/L $27.30/$20.75)

DR Horton Inc. (DHI: Quote) is expected to report results for the first quarter before the markets open. The earnings of the homebuilder are expected to increase to $0.14 per share from $0.09 per share reported a year earlier. Quarterly revenues are estimated to grow to $1.10 billion from last year's $884.30 million. On Monday, the stock closed at $21.31. (52-wk H/L $22.79/$13.45)

Drugmaker Eli Lilly & Co. (LLY: Quote) is also scheduled to report fourth quarter results before the start of trading. The Indianapolis, Indiana-based company's earnings are expected to decline to $0.78 per share from $0.87 per share reported a year earlier. Quarterly revenues are anticipated to fall to $5.81 billion from last year's $6.05 billion. The company's shares closed Monday's session at $52.64. (52-wk H/L $53.99/$38.30)

Automaker Ford Motor Co. (F: Quote) is slated to report results for the fourth quarter. Earnings and revenue for the quarter are expected to be $0.25 per share and $32.94 billion respectively. In the previous year, the Dearborn, Michigan-based company posted earnings of $0.20 per share on revenues of $32.60 billion. The stock closed Monday at $13.78. (52-wk H/L $14.30/$8.82)

Boston Scientific Corp. (BSX: Quote) will report its fourth-quarter results today. The company is expected to post earnings of $0.11 per share, up from $0.08 per share reported a year earlier, while quarterly revenues are anticipated to decline to $1.76 billion from last year's $1.85 billion. The company's shares closed Monday's session at $6.86. (52-wk H/L $6.93/$4.79)

Chipmaker Broadcom Corp. (BRCM: Quote) is expected to post fourth quarter results after the markets close. The company is expected to earn $0.73 per share, higher than the prior year's $0.68 per share on revenues of $2.07 billion. The company's shares closed Monday's regular trading at $34.06. (52-wk H/L $39.66/$28.60)

Ashland Inc. (ASH: Quote), CIT Group Inc. (CIT: Quote), Corning Inc. (GLW: Quote), Danaher Corp. (DHR: Quote), EMC Corporation (EMC: Quote), Harley-Davidson, Inc. (HOG: Quote), Illinois Tool Works Inc. (ITW: Quote), Kulicke and Soffa Industries, Inc. (KLIC: Quote), Lexmark International Inc. (LXK: Quote), Nucor Corporation (NUE: Quote), Peabody Energy Corp. (BTU: Quote), Tupperware Brands Corporation (TUP: Quote), United States Steel Corp. (X: Quote), Tyco International Ltd. (TYC: Quote), Valero Energy Corporation (VLO: Quote), ACE Limited (ACE: Quote), Arthur J Gallagher & Co. (AJG: Quote), Boston Properties Inc. (BXP: Quote), Dolby Laboratories, Inc. (DLB: Quote), Freescale Semiconductor, Ltd. (FSL: Quote), Hutchinson Technology Inc. (HTCH: Quote), Manhattan Associates, Inc. (MANH: Quote), PAREXEL International Corporation (PRXL: Quote), Spansion Inc. (CODE: Quote), Unisys Corporation (UIS: Quote) and Websense, Inc. (WBSN: Quote) are also slated to report their results.

Register
To receive FREE breaking news email alerts for Pfizer Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A Thai company has bought iconic U.S. tuna brand Bumble Bee for $1.51 billion dollars. Thai Union Frozen Products Public Company Limited or TUF, the world's largest processor of shelf-stable tuna products snapped up Bumble Bee from private equity firm Lion Capital. Post Synergies, the transaction... Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and... Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.